VistaGen Therapeutics
Price & Volume
Stats
See more52W Range | $0.43-$5.14 |
Market Cap | $24.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $789,000 |
Revenue Growth (YoY) | 29.5% |
Gross Profit (12 Mos) | $789,000 |
Diluted EPS | -$1.90 |
News
See moreYahoo Finance • 3 days ago
Kuehn Law Encourages Investors of Vistagen Therapeutics, Inc. to Contact Law Firm
Yahoo Finance • 2 months ago
VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
About
CEO | Mr. Shawn K. Singh J.D. |
CFO | Mr. Nick B. Tressler M.B.A. |
Address | 343 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |